← FDA Drug Approvals (Drugs@FDA)
TRILYTE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA USA · Approved 2004-02-05
Drug application
- FDA Application #
ANDA076491- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TRILYTE
- Generic name
- POLYETHYLENE GLYOCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE
- Active ingredients
- POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
- Dosage form
- FOR SOLUTION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- AUROBINDO PHARMA USA
- Manufacturer
- Aurobindo Pharma Limited
- First approval
- 2004-02-05
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown